Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 1 129 INR 11.11%
Market Cap: 23.5B INR
Have any thoughts about
Windlas Biotech Ltd?
Write Note

Net Margin
Windlas Biotech Ltd

9%
Current
8%
Average
0.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9%
=
Net Income
596m
/
Revenue
6.6B

Net Margin Across Competitors

Country IN
Market Cap 23.2B INR
Net Margin
9%
Country US
Market Cap 1.3T USD
Net Margin
6%
Country US
Market Cap 208.7B USD
Net Margin
14%
Country US
Market Cap 177.4B USD
Net Margin
18%
Country KR
Market Cap 71.4T KRW
Net Margin
24%
Country CH
Market Cap 38.8B CHF
Net Margin
9%
Country US
Market Cap 37.5B USD
Net Margin
9%
Country US
Market Cap 37.5B USD
Net Margin
22%
Country US
Market Cap 27.4B USD
Net Margin
21%
Country US
Market Cap 22.9B USD
Net Margin
-69%
Country US
Market Cap 22.3B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Windlas Biotech Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9%
=
Net Income
596m
/
Revenue
6.6B
What is the Net Margin of Windlas Biotech Ltd?

Based on Windlas Biotech Ltd's most recent financial statements, the company has Net Margin of 9%.